Search Results
Results found for "Marc Chabre"
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
Instructors at the course included Marc Chabre , Harden McConnell , Richard Henderson , Martin Rodbell
- A journey from Duke to McGill along the dopamine circuit
After a doctoral training at the Pierre and Marie Curie University in Paris and a short internship at From 91 to 94, he was an assistant professor at Duke University in North Carolina, working with Marc Since 2008, he arrived at McGill University with a Canada Research Chair.
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
Marc G. He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
Marc G. He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr
- GPCR Retreat 2023 | Dr. GPCR Ecosystem
lived up to the expectations by putting together an outstanding program with a special thought for Marc activity-modifying proteins or RAMPs regulate GPCR function, is confirmed as Plenary Speaker of the inaugural Marc Additionally, there will be a Marc G.
- Dr. Bruno Giros | Dr. GPCR Ecosystem
After doctoral training at the Pierre and Marie Curie University in Paris and a short internship at Genentech From 91 to 94, he was an assistant professor at Duke University in North Carolina, working with Marc Since 2008, he has arrived at McGill University as a Canada Research Chair.
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
Caron Tribute Part 3 About Marc Caron Dr. Marco Pardo (2002) Dr. Vania Prado (2002) Dr. Amy Ramsey (2008) Dr. Bryan Roth (current) Dr.
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
Marc Caron at Duke University for his post-doctoral training. In the Caron lab, Dr.
- Dopamine-Mediated Motor Recovery after Ischemic Stroke
Marc Caron, where I cloned the dopamine D5 receptor gene and investigated the regulation of dopaminergic
- Dr. Caron Tribute Part 2 | Dr. GPCR Ecosystem
Caron Tribute Part 2 About Marc Caron Dr.
- Dr. Caron Tribute Part 1 | Dr. GPCR Ecosystem
Caron Tribute Part 1 About Marc Caron Dr.
- Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology
Marc Caron (2019-2023) and subsequently, will begin my independent research career as a tenure-track
- Dr. Richard Premont | Dr. GPCR Ecosystem
Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert Lefkowitz and Marc
- Dr. Richard Premont | Dr. GPCR Ecosystem
Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert Lefkowitz and Marc
- Dr. Richard Premont | Dr. GPCR Ecosystem
Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert Lefkowitz and Marc
- Dr. Richard Premont | Dr. GPCR Ecosystem
Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert Lefkowitz and Marc
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
Eldridge Distinguished Professor and Chair of the Department of Cell Biology & Physiology at The University Marc G. Caron at Duke University. Dr.
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Marc G. Caron at Duke University. Dr.
- Mark Schmeizl | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Mark Schmeizl About Mark Schmeizl Mark leverages 30 years Mark believes professional placement should be about matching talented people with companies where they Mark Schmeizl on the web Website LinkedIn Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast?
- Illuminating Functional Selectivity and Allosterism at GPCRs.
He has received many awards, including a Canada Research Chair, FRSQ scholarships and the CDA/CSEM/Merck The Canadian Institutes for Health Research and March of Dimes currently support his research."
- Our History | Dr. GPCR Ecosystem
Community Engagement Mar 2022 — Featured at ERNEST with Dr. Mar 2022 — Featured at ERNEST with Beyond the Lab . Mar 2022 — Media Partner at GPCR Targeted Drug Discovery Summit . Marc Caron Tribute Episodes ( #100 , #101 & #102 ), featuring over 30 expert guests , including Dr. Community Engagement Mar 2024 — Media Partner at 3rd GPCR Targeted Drug Discovery Summit .
- Dr. Mark Connor | Dr. GPCR Ecosystem
Mark Connor About Dr. Mark Connor Undergraduate BSc with Honours in Pharmacology from University of Sydney (1987, snake neurotoxins Postdoc with Graeme Henderson (Bristol, opioids and Ca signaling) and Mac Christie (Sydney, opioids in Mark Connor on the web Researchers Twitter Google Scholar Dr. GPCR Ecosystem Enjoying the Dr.
- GPCR Retreat Schedule 2023
: RAMP-interacting GPCR Pathways Inaugural Marc G. Caron Keynote Lecture Kathleen M.
- Structure-based discovery of functionally selective 5-HT1A receptor agonists
Peter has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander University Erlangen-Nürnberg and declined an offer for the Chair for Pharmaceutical Chemistry at the
- Anything BUT GPCRs with Dr. Mikel Garcia-Marcos | Dr. GPCR Ecosystem
Mikel Garcia-Marcos About Dr. Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain Mikel Garcia-Marcos, the host Yamina explores Dr. Garcia-Marcos's academic journey, which spans training in Spain, Belgium, and a postdoctoral fellowship Mikel Garcia-Marcos on the web Boston University LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast?
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
Nagarajan Vaidehi "Nagarajan Vaidehi, Ph.D., is professor and chair of the Department of Computational Vaidehi joined the Beckman Research Institute of the City of Hope in 2006 as a Professor and became chair
- ⏳ In case you haven’t heard—registration for “Development of GPCR Ligands as Therapeutic Drugs” closes March 18th! If you’re working on GPCR drug discovery, you know that finding a promising candidate is just the start. A drug must also: ✅ Be absorbed into the body ✅ Reach the right target ✅ Stay long enough to be effective ✅ Cause no harm 📢 Spots are limited—register by March 18th! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #Biotech #DrugDiscovery | Dr. GPCR Ecosystem
In case you haven’t heard—registration for “Development of GPCR Ligands as Therapeutic Drugs” closes March the right target ✅ Stay long enough to be effective ✅ Cause no harm 📢 Spots are limited—register by March GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #Biotech #DrugDiscovery Published on March 10, 2025 Category In case you haven’t heard—registration for “Development of GPCR Ligands as Therapeutic Drugs” closes March the right target✅ Stay long enough to be effective✅ Cause no harm 📢 Spots are limited—register by March
- State of the Art Talk | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Würzburg, Germany); 2016: Heisenberg professorship (Würzburg, Germany); 2016-to date: Professor and Chair
- 🎯 Crack the code of GPCR ligand development! In case you haven’t heard, Dr. Terry Kenakin is hosting a 4-week course on GPCR drug development—and registration closes in 3 days! ⚠️ What you’ll learn: ✅ Drug absorption, metabolism & clearance ✅ PK-PD modeling & therapeutic profiles ✅ Early safety assessments & toxicity risks 📌 Limited spots—sign up before March 18th! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research | Dr. GPCR Ecosystem
& therapeutic profiles ✅ Early safety assessments & toxicity risks 📌 Limited spots—sign up before March GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research Published on March 15, 2025 Category Dr. modeling & therapeutic profiles✅ Early safety assessments & toxicity risks 📌 Limited spots—sign up before March
- Complex Allosteric Cannabinoid Receptor Pharmacology
Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and

























